A recombinant human scFv anti-Rh(D) antibody with multiple valences using a C-terminal fragment of C4-binding protein

Blood

Volumn 90, Issue 10, 1997, Pages 3978-3983

  Tonye Libyh, M ^b   Goossens, D ^b   Oudin, S ^b   Gupta, N ^b   Dervillez, X ^b   Juszczak, G ^b   Cornillet, P ^b   Bougy, F ^b   Reveil, B ^b   Philbert, F ^b   Tabary, T ^b   Klatzmann, D ^b   Rouger, P ^b   Cohen, J H M ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; RHESUS ANTIBODY;

ALLOIMMUNITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CARBOXY TERMINAL SEQUENCE; ERYTHROCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; STRUCTURE ACTIVITY RELATION; TARGET CELL;

EID: 1842411843     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.3978     Document Type: Article

References (34)

1. Hillarp A, Dahlbäck B: Cloning of cDNA coding for β-chain of human complement component C4b-binding protein: Sequence homology with the α-chain. Proc Natl Acad Sci USA 87:1183, 1990
2. Hillarp A, Dahlbäck B: Novel subunit in C4b binding protein required for protein S binding. J Biol Chem 263:12759, 1988
3. Rodriguez de Cordoba S, Sanchez-Corral P, Rey Campos J: Structure of the gene coding for the alpha polypeptide chain of the human complement C4b-binding protein. J Exp Med 173:1073, 1991
4. Hillarp A, Pardo-Manuel F, Ruiz RR, Rodriguez de Cordoba S, Dahlbäck B: The human C4b-binding protein β-chain gene. J Biol Chem 268:15017, 1993
5. Scharfstein J, Ferreira A, Gigli I, Nussenzweig V: Human C4-binding protein I. Isolation and characterization. J Exp Med 148:207, 1978
6. Goossens D, Champomier F, Rouger P, Salmon C: Human monoclonal antibodies against blood group antigens. J Immunol Method 101:193, 1987
7. Marks JD, Hoogenboom HR, Bonnert T, Mc Cafferty AD, Griffiths J, Winter G: Bypassing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222:581, 1991
8. Marks JD, Tristem M, Karpas A, Winter G: Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family specific oligonucleotide probes. Eur J Immunol 21:985, 1991
9. Hoogenboom HR, Griffiths AD, Johnson KS, Chriswell DJ, Hudson P, Winter G: Multi-subunit proteins on the surface of filamentous phage: Methodologies for displaying antibody (Fab) heavy and light chains. Nucl Acids Res 19:4133, 1991
10. Munro S, Pelham HRB: An Hsp70-like protein in the ER: Identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 46:291, 1986
11. Better M, Chang CP, Robinson R, Horwitz AH: Escherichia coli secretion of an active chimaeric antibody fragment. Science 240:1041, 1988
12. Van Doren K, Hanahan D, Cluzman Y: Injection of eucaryotic cells by helper independent recombinant adenoviruses: Early region 1 is not obligatory for integration of viral DNA. J Virol 50:606, 1984
13. Deen KC, Mc Douglas JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Richard A, Sweet RW: A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331:82, 1988
14. Evans GI, Lewis GK, Ramsay G, Bishop JM: Isolation of monoclonal antibodies specific for human c-Myc. Mol Cell Biol 5:3610, 1985
15. Steinbuch M, Audran R: The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys 134:279, 1969
16. Laemmli UK: Cleavage of stuctural proteins during the assembly of the head of bacteriophage T4. Nature 277:680, 1970
17. Cohen JH, Aubry JP, Jouvin MH, Wijdenes J, Bancherau J, Kazatchkine M, Revillard JP: Enumeration of CR1 complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flow cytometry. J Immunol Method 99:53, 1987
18. Edelman L, Blanchard D, Rouger P, Doinel C, Cartron JP, Salmon C, Reviron J: A monoclonal antibody directed against the homologous N-terminal domain of glycophorin A and B. Exp Clin Immunogenet 1:129, 1984
19. Carter P, Kelley RF, Rodriguez ML, Snedecor B, Covarrubias M, Velligan MD, Wong WLT, Rowland AM, Kotts CE, Carver ME, Yang M, Bourell JH, Shepard HM, Henner D: High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Biotechnology 10:163, 1992
20. Skerra A, Plückthun A: Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240:1038, 1988
21. Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope HS, Riordan GS, Whitlow M: Single-chain antigen-binding proteins. Science 242:423, 1988
22. Katre NV, Knauf MJ, Laird WJ: Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc Natl Acad Sci USA 84:1487, 1987
23. Ito W, Kurosawa Y: Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A. J Biol Chem 268:20668, 1993
24. Landolfi NF: A chimeric IL-2/Ig molecule possesses the functional activity of both proteins. J Immunol 146:915, 1991
25. Vié H, Gauthier T, Breathnach R, Bonneville M, Godard A, Dietrich J, Karam G, Gesnel MC, Peyrat MA, Soulillou JP: Human fusion proteins between interleukin 2 and IgM heavy chain are cytotoxic for cells expressing interleukin 2 receptor. Proc Natl Acad Sci USA 89:11337, 1992
26. Smith RIF, Morrison SL: Recombinant polymeric IgG: Approach to engineering more potent antibodies. Biotechnology 12:683, 1994
27. Smith RIF, Coloma MJ, Morrison SL: Addition of a μ-tail-piece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4. J Immunol 154:2226, 1995
28. Schäffner M, François C, Kaluza B, Jacques Y, Weidle UH: Chimeric interleukin 2 receptor alpha chain antibody derivatives with fused mu and gamma chains permit improved recruitment of effector functions. Mol Immunol 32:9, 1995
29. Traunecker A, Schneider J, Kiefer H, Karjalainen K: Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature 339:68, 1989
30. Kostelny SA, Cole MS, Tso JY: Formation of a bispecific antibody by the use of leucine zippers. J Immunol 148:1547, 1992
31. Pack P, Plückthun A: Miniantibodies: Use of amphiphatic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli. Biochemistry 31:1579, 1992
32. Lovejoy B, Choc S, Cascio D, McRorie DK, De Grado WF, Eisenberg D: Crystal structure of a synthetic tripled-stranded α-helical bundle. Science 259:1288, 1993
33. Holliger P, Prospero T, Winter G: Diabodies: Small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA 90:6444, 1993
34. Dübel S, Breitling F, Kontermann R, Schimdt T, Skerra A, Little M: Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv). J Immunol 178:201, 1995